Video
Video
Lorcaserin shows CV safety in CAMELLIA-TIMI 61
It’s the first weight-loss drug ever to show cardiovascular safety, Dr. Erin Bohula said in an interview.
Video
Special care advised for HIV-infected patients with diabetes
Unique challenges require adjustments to normal diagnostics and treatment, endocrinologist says
Video
RISE: Insulin glargine, metformin offer no beta cell function benefit in youth
ORLANDO – Findings from pediatric portions of RISE, a T2DM medication study, are disappointing but lay strong foundation for future studies in...
Video
Chronic kidney disease is 40% more common in T2DM than T1DM
ORLANDO – Analysis of 1.5 million U.S. subjects reinforces importance of early warning via albumin testing.
Conference Coverage
Intensive treatment for T2D pays off in the long run
ORLANDO – Long-term follow-up of the Steno-2 study confirms that intensive therapy for type 2 diabetes saves money because of reduced...
Conference Coverage
Diabetes patients pushed into high-deductible plans
ORLANDO – The proportion of diabetes patients enrolled in high-deductible health plans jumped from 10% in 2005 to...
Video
Eversense CGM shown safe, accurate for 180 days in adolescents
ORLANDO –
Conference Coverage
Switch back to human insulin a viable money saver
ORLANDO – Hypoglycemia admissions were flat while HbA1c rose slightly.
Conference Coverage
T1D neuropathy declines as glycemic control improves
ORLANDO – New research suggests the rate may have dipped, possibly due to better glycemic control.
Video
Semaglutide drops HbA1c, weight, across ethnicities
BOSTON – In T2DM, glycemic control was significantly improved across the SUSTAIN trials.